BCAN is committed to supporting . Our goal is to identify the best and most promising research that will provide the greatest opportunity to advance the understanding of Research Network (BRCN) Management Committee and how to improve management and treatment of this disease. BCAN raises funds and awards grants to support innovative research to develop lifesaving treatments.research. From its inception, BCAN has cultivated a strong partnership with the leading members of the medical community to encourage collaboration among all the parties dedicated to the study of and its prevention, diagnosis and treatment. Starting in 2010, BCAN provided $25,000 one-year grants to support young investigators conducting research. In 2011 BCAN received a generous multi-year gift from Raymond and Maria Floyd, for the Raymond and Maria Floyd Award for Research in 2011 and 2012. BCAN’s current research priorities are guided by the
Information about applying for awards in 2016 Young Investigator Awards and firstname.lastname@example.org.Research Innovation Award is available below, and in March 2016 for the John Quale Travel Fellowship Program. Please contact BCAN if you have any questions at
A new award for 2014, BCAN announces theResearch Innovation Award of $300,000 over a two-year period for an experienced investigator who will break new ground in the field of . The aim of the award is to support exceptionally novel and creative projects with great potential to produce breakthroughs in the management of .
2016Research Innovation Award Winner
THE JPB FOUNDATION RESEARCH INNOVATION AWARD
David McConkey, M.D., Ph.D.
Director at the Johns Hopkins Greenberg Institute in Baltimore, MD.
“Targeting FGFR3 in muscle-.”
2015Research Innovation Award Winner
JAMES FAMILY FOUNDATION AND PARTNER FUND MANAGEMENTRESEARCH INNOVATION AWARD
Cory Abate-Shen, Ph.D.
Professor of Urological Oncology at Columbia University Medical Center and Associate Director of Translational Research at the Herbert Irving Comprehensive Cancer Center
“Epigenetic regulation ofprogression.”
2014Research Innovation Award Winner
JAMES FAMILY FOUNDATION AND PARTNER FUND MANAGEMENT –RESEARCH INNOVATION AWARD
William Kim, MD
Associate Professor of Medicine, Urology, and Genetics at the University of North Carolina at Chapel Hill and UNC Lineberger Comprehensive Cancer Center
“Immune Characterization of High-
Click here to view press release
Raising the bar on research, BCAN launched its Young Investigator Awards in 2013. These grants fund researchers who may be working in basic, translational, clinical, epidemiologic, bioengineering or any other scientific or research field, but are also working in a research environment capable of supporting transformationalresearch. BCAN would like to recognize the generosity of The JPB Foundation for under-writing two of the 2014 Young Investigator Awards. The New York based philanthropy works to enhance the in the United States through transformational initiatives that promote the health of our communities by creating opportunities for those in poverty, promoting pioneering medical research, and enriching and sustaining our environment. The program was seeded through a $250,000 challenge grant received from the Gerald C. McNamara and Renée K. Petrofes Charitable Fund. BCAN responded by raising more than $500,000 in additional private funds to further develop the program.
2016 Young Investigator Award Winners
|Niannian Ji, PhD||Kent Mouw, MD, PhD|
The Stephen Hale Gushée Young Investigator Award will support Kent William Mouw, M.D., Ph.D. of Dana-Farber Cancer Institute, for his research “Identifying Genomic Determinants of Chemoradiotherapy Response in Muscle-.” Dr. Mouw’s study will leverage new genomic techniques to better understand how these biomarkers can benefit muscle patients treated with combined modality therapy.
The JPB Foundation Young Investigator Award will further the work of Niannian Ji, Ph.D. of the University of Texas Health Science Center at San Antonio for her project on the “Role of antigen-specific immunity in BCG therapy for.” Dr. Ji’s study will provide key mechanistic insights into BCG efficacy in treating and establish a framework for rapid development of BCG combination strategies to combat BCG resistance in patients.
2015 Young Investigator Award Winners
|Philip Palmbos, MD, PhD||Rahul Parikh, MD, PhD|
Philip Palmbos, M.D., Ph.D.Clinical Lecturer, University of Michigan – “The Role of TP63 and ATDC in Invasive Bladder Cancers.” Dr. Palmbos will continue his work focusing on a novelthat drives cells to as well as to become resistant to treatment. This work is directed at the improved characterization of the mechanisms underlying this invasion to identify pathways that may be targeted to prevent growth and progression.
THE STEPHEN HALE GUSHÉE YOUNG INVESTIGATOR AWARD
Rahul Parikh, M.D., Ph.D., Assistant Professor, University of Pittsburgh – “The Role of ATM Loss and the ATR-CHK1 Pathway in .”
2014 Young Investigator Award Winners
BCAN YOUNG INVESTIGATOR AWARD
Sunny Guin, PhD, Postdoctoral Fellow, University of Colorado at Denver, for his project “The Role, Relationship and Therapeutic Potential of HAS2 and AGL in .” Dr. Guin will be investigating a novel signaling pathway and potential drug-able target for formation, aggressiveness, and .
THE JPB FOUNDATION YOUNG INVESTIGATOR AWARD
Ryoichi Saito, MD, PhD, Research Associate, University of North Carolina at Chapel Hill, for his project, “Consequences of ARID1A Inactivation in .” Dr. Saito will be expanding the findings from The Cancer Genome Atlas Project in , specifically focusing on a mutated in one of the most frequently altered pathways to better characterize its mechanism in development. He will also be developing a novel mouse model for .
THE JPB FOUNDATION YOUNG INVESTIGATOR AWARD
Dmitriy Zamarin, MD, PhD Hematology/Oncology Fellow, Memorial Sloan-Kettering Cancer Center, for his project “Defining Targets in Microenvironment Using Oncolytic Viruses.” Dr. Zamarin is examining using an oncolytic virus to activate the immune system to recognize cancer cells, and combined with other immunotherapies to combat metastatic . Dr. Zamarin will also work on identifying immune resistance mechanisms in .
2013 Young Investigator Award Winners
BCAN YOUNG INVESTIGATOR AWARD
David DeGraff, Ph.D., Postdoctoral Fellow, Vanderbilt University Medical Center. Project Title: Transcriptional Control of Tumorigenesis. The award will help support Dr. DeGraff’s research to investigate expression of two transcription factors which regulate cell behavior: FOXA1 and AP2 gamma, and their role in risk.
JAMES FAMILY YOUNG INVESTIGATOR AWARD
Gopa Iyer, MD, Clinical Instructor, Memorial Sloan-Kettering Cancer Center. Project Title: Identifying Predictors of Response to mTOR-targeted Therapies in . The award will support Dr. Iyer’s research to examine the role of the Tuberous Sclerosis 1 (TSC1) in tumors and improve understanding of the genetic alterations in to identify patients who will most likely benefit from targeted therapies in this disease.
RAYMOND AND MARIA FLOYD FAMILY YOUNG INVESTIGATOR AWARD
Debashis Sahoo, PhD, Instructor, Stanford University. Project Title: High resolution molecular analysis of CD47-mediated immune escape in . The award will support Dr. Sahoo’s research to investigate interactions between the immune system and specifically looking at CD47 variants.
Started in 2009, the John Quale Travel Fellowship Program provides $1700 awards to defray travel-related costs for early career investigators interested in click here.research to attend the annual Think Tank Meeting, a unique opportunity to meet and learn from leaders in the field. The primary mission of this meeting is to enhance collaboration among physicians and researchers who are dedicated to the prevention, diagnosis, and treatment of . The Travel Fellowship Program seeks to engage more early-career individuals with interests related to including basic scientists, urologists, oncologists, and pathologists. For more information about this program please
2016 John Quale Travel Fellows
Samuel Funt, M.D.,Fellow, Memorial Sloan-Kettering Cancer Center, New York, NY
Matthew Mossansen, MD, Urologic Oncology Fellow, Massachusetts General Hospital
Tracy Rose, M.D., Hematology/Oncology Fellow, The University of North Carolina at Chapel Hill, NC
Debasish Sundi, M.D., Post-doctoral Fellow, University of Texas M.D. Anderson Cancer Center, Houston, TX
2015 John Quale Travel Fellows
Abdul R. Banday, Ph.D., M.S., Postdoctoral Fellow, Laboratory of Translational Genomics National Cancer Institute, NIH NCI Division of Cancer Epidemiology and Genetics “Genetic and functional analysis and translational development of the chromosome 3q28 signal identified by genome-wide association studies of urinary.”
Max Kates, M.D. Resident, Department of Urology Johns Hopkins Medical Institutions
Huyen T. Nguyen, Ph.D. Postdoctoral Researcher, Department of Radiology The Ohio State University “Non-invasive quantification of microcirculation heterogeneity as a biomarker for the diagnosis and response prediction of.”
Randy Sweis, M.D. Fellow, Division of Hematology/Oncology The University of Chicago “Characterization ofimmunologic subtypes and immune therapy resistance mechanisms.”